跳至主要内容
临床试验/NL-OMON35382
NL-OMON35382已完成不适用

Exercise therapy and cognitive behavioural therapy in Postpoliomyelitis Syndrome: effects on fatigue, activities and quality of life. - FACTS-2-PPS

Academisch Medisch Centrum0 个研究点目标入组 81 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
81

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • (1) diagnosis of PPS according to the criteria of March and Dimes i.e.
  • a. A confirmed history of paralytic poliomyelitis characterized by an acute illness with fever and a usually asymmetrically distributed, flaccid paresis of a varying number of muscle groups. Evidence of motor neuron loss on neurological examination with signs of residual weakness, atrophy, loss of tendon reflexes and intact sensation.
  • b. A period of partial or complete functional recovery after acute paralytic poliomyelitis, followed by an interval (usually 15 years or more) of stable neurologic function.
  • c. Gradual or sudden onset of progressive and persistent new muscle weakness or abnormal muscle fatigability (decreased endurance), with or without generalized fatigue, muscle atrophy, or muscle and joint pain. Symptoms persist for at least a year.
  • d. No other medical diagnosis to explain the symptoms (anemia and thyroid dysfunction
  • as a cause of fatigue will be ruled out by blood test).
  • (2) suffering from severe perceived fatigue (CIS-fatigue ><= 35)
  • (3) age between 18 and 70 years
  • (4) a life-expectancy longer than one year
  • (5) consultation (not necessarily the first consultation) of a neurologist or physical medicine and rehabilitation specialist in the previous 5 years
  • (6) walking-ability at least indoors with or without a walking aid
  • (7) ability to cycle on a bicycle ergometer against a load of at least 25 Watt.

排除标准

  • (1) cognitive impairment
  • (2) insufficient mastery of the Dutch language
  • (3) pregnancy
  • (4) use of psychotropic drugs (except simple sleeping medication) or other psychiatric treatment.
  • (5) use of medication causing fatigue
  • (6) disabling co-morbidity interfering with the intervention programs or influencing outcome
  • parameters (including cardiopulmonary disease like chest pain, arrhythmia, pacemaker, cardiac surgery, severe dyspnoea d*effort or emphysema, epileptic seizures, poorly regulated diabetes mellitus).
  • (7) respiratory insufficiency

研究者

相似试验